NCT03267329已完成4 期
A Randomized, Open, Parallel, Multicenter, Phase 4 Study to Evaluate the Central Aortic Pressure Effect Between Fixed Dose Combination (Duowell® Tab) and Monotherapy of Telmisartan in Mild Dyslipidemia Patients With Hypertension
Yuhan Corporation1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年9月11日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Changes from baseline in mean central systolic blood pressure
研究概览
简要总结
This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Duowell® Tab.
Experimental
Once daily during 16 wks
干预措施: Duowell® (Drug)
Telmisartan
Active Comparator
Once daily during 16 wks
干预措施: Telmisartan (Drug)
结局指标
主要结局
Changes from baseline in mean central systolic blood pressure
时间窗: at week 16
次要结局
- Changes from baseline in mean brachial systolic blood pressure(at week 4 and at week 16 and at week 28)
- Changes from baseline in carotid femoral pulse wave velocity(at week 16 and at week 28)
- Changes from baseline in mean brachial pulse pressure(at week 4 and at week 16 and and at week 28)
- Changes from mean brachial diastolic blood pressure(at week 4 and at week 16 and at week 28)
- Changes from baseline in augmentation index(at week 16 and at week 28)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
CKD-828 Telmisartan Non-Responder TrialHypertensionNCT01426100Chong Kun Dang Pharmaceutical183
已完成
2 期
A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaAsthmaNCT01656811Sumitomo Pharma America, Inc.146
已完成
2 期
Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)Dementia Associated With Parkinson's DiseaseDementia With Lewy BodiesNCT00630500Helse Stavanger HF75
招募中
2 期
TB006 for Autism Spectrum DisorderAutism Spectrum DisorderNCT06500637Rossignol Medical Center45
已完成
4 期
Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis ParticipantsRheumatoid ArthritisNCT02573012Hoffmann-La Roche314